A generic-drug trade group is suing Maryland over a price-gouging law that is set to go into effect in October. In a federal lawsuit filed Thursday against state Attorney General Brian E. Frosh, D, and Dennis Schrader, the Secretary of ...Read More »
The Justice Department accused two executives of colluding with other generic pharmaceutical companies to fix prices, the first criminal charges stemming from a sweeping two-year investigation. Jeffrey Glazer, a former chief executive officer of Heritage Pharmaceuticals Inc., and Jason Malek, ...
Tagged with: drug pricesRead More »
WASHINGTON — Lawmakers are venting outrage over high prescription drug costs, but if Congress is looking for culprits, it might want to look in the mirror. Republican- and Democratic-controlled Congresses, and presidents of both parties, may have set the ...Read More »